Bybit has introduced a new USDT-margined perpetual contract for KiiChain (KII) in its Innovation Zone, allowing traders to use leverage up to 5x. This contract uses Tether (USDT) as the margin currency and expands trading options for KiiChain, a blockchain platform focused on stablecoins and real-world assets for cross-border payments and financial services. The launch follows similar offerings from Gate and OKX, which provide higher leverage up to 20x. This move broadens access to KiiChain derivatives in the crypto market.
Bybit's launch of the KiiChain (KII) perpetual contract with 5x leverage adds to the expanding crypto derivatives market. For readers following major cryptocurrencies on Pluang, here is the market snapshot as of Sep 28, 2026 17:02 WIB: out of 50 priced major cryptocurrencies, 8 rose and 41 fell. Notable movers include ATOM at Rp31.572 with a 1-day change of -7.13% and a typical hold time of 60 days, COMP at Rp412.843 down 6.74% with a hold time of 97 days, and CRV at Rp5.876 down 6.69% with a hold time of 62 days. Pluang order activity shows a strong sell bias for ATOM (80% Sell) and a strong buy bias for COMP (93% Buy).
Cellebrite DI Ltd. is under investigation by Kaplan Fox & Kilsheimer LLP for potential securities violations after the company missed its second-quarter revenue targets and cut its full-year guidance. The company reported $507.8 million in annual rec...
TransCode Therapeutics announced updated Phase 1a trial results for TTX-MC138, an RNA-based cancer therapy targeting advanced solid tumors. Among 14 evaluable patients, 71.4% achieved stable disease, with over half maintaining control through three m...
Pest control and sanitation companies Rollins, Rentokil, and Ecolab maintain strong customer contract renewals even as two of the three stocks have seen significant price declines this year. These companies operate on recurring service contracts that...
Lakewood-Amedex Biotherapeutics announced positive clinical isolate data for Nu-3, their lead antimicrobial candidate targeting infected diabetic foot ulcers (iDFU). Nu-3 demonstrated strong bactericidal activity against resistant pathogens like MRSA...
Verizon's stock, yielding 6.01%, has cooled recently despite a strong year, but new growth catalysts are emerging. The company is expanding its fiber network through the Frontier deal, aiming for over 32 million fiber passings by year-end and signifi...
